Atlas Trials

SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma

Clinical trial NCT05524168 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05524168
Sponsor
Sun Yat-sen University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2022-11-25
Primary completion
2025-06-06
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.